Ultralife Corporation
ULBI
$6.94
$0.040.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -6.50% | 10.56% | 21.51% | 12.98% | 21.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.50% | 10.56% | 21.51% | 12.98% | 21.03% |
| Cost of Revenue | -1.60% | 9.54% | 24.95% | 17.57% | 24.57% |
| Gross Profit | -21.05% | 13.75% | 10.79% | 0.50% | 11.64% |
| SG&A Expenses | -3.45% | 15.57% | 22.35% | 21.97% | 19.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.60% | 10.79% | 25.18% | 18.13% | 24.38% |
| Operating Income | -82.69% | 6.89% | -146.91% | -38.40% | -10.14% |
| Income Before Tax | -127.11% | -2,161.82% | -596.03% | -71.06% | -32.19% |
| Income Tax Expenses | -133.86% | -1,150.76% | -781.08% | -71.51% | -19.35% |
| Earnings from Continuing Operations | -125.07% | -3,298.71% | -546.95% | -70.93% | -35.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 242.86% | 179.49% | 228.57% | 137.50% | -7.69% |
| Net Income | -124.18% | -3,925.77% | -572.87% | -70.39% | -35.49% |
| EBIT | -82.69% | 6.89% | -146.91% | -38.40% | -10.14% |
| EBITDA | -60.99% | 8.13% | -39.49% | -22.34% | -0.50% |
| EPS Basic | -124.17% | -3,909.40% | -572.90% | -70.54% | -36.42% |
| Normalized Basic EPS | -91.94% | 107.93% | -295.33% | -66.36% | -26.48% |
| EPS Diluted | -127.27% | -4,304.72% | -572.90% | -72.10% | -37.61% |
| Normalized Diluted EPS | -91.92% | 109.38% | -298.10% | -65.91% | -26.09% |
| Average Basic Shares Outstanding | 0.14% | 0.15% | 0.13% | 0.40% | 1.45% |
| Average Diluted Shares Outstanding | -0.14% | -0.64% | -1.35% | -1.00% | 0.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |